Ayuvant - Crunchbase Company Profile & Funding

Q: Where is Ayuvant's headquarters?

Ayuvant is located in Utrecht, Utrecht, The Netherlands.

Q: Who invested in Ayuvant?

Ayuvant is funded by Draper Cygnus.

Q: When was the last funding round for Ayuvant?

Ayuvant closed its last funding round on obfuscated from a Seed round.

Overview

Ayuvant

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ayuvant

CB Rank

307490

Ayuvant is a Biotechnology company engaged in the research and development of RNA-based immunotherapies for oncology patients.

Founded

obfuscation

Private

Seed

Utrecht, Utrecht, The Netherlands

1-10

www.ayuvant.com/

Biotechnology

Health Care

Hospital

Life Science

Pharmaceutical

Wellness

Funding Rounds

Seed

OBF

obfuscation

Details

Operating Status

Active

Company Type

For Profit

About the Company

Ayuvant is a Biotechnology company engaged in the research and development of RNA-based immunotherapies for oncology patients and to boost the effectiveness of RNA medicines.

Contact Email

info@ayuvant.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RNA-nanoparticle Immunotherapy

An RNA-based immunotherapy that instructs the immune system to recognize and attack cancer cells, designed for oncology patients resistant to immune checkpoint inhibitors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Ayuvant	1	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Draper Cygnus	—	Seed Round - Ayuvant	—
Draper Cygnus	—	Seed Round - Ayuvant	—
Draper Cygnus	—	Seed Round - Ayuvant	—
Draper Cygnus	—	Seed Round - Ayuvant	—
Draper Cygnus	—	Seed Round - Ayuvant	—